Testing high doses of favipiravir in healthy volunteers
Treatments studied
Part of Infections clinical trials.
This study tests the safety and how the body processes very high doses of the antiviral drug favipiravir in healthy people. It helps find the highest dose that is still safe before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 50-75 or a woman aged 18-75.
- You are generally healthy based on a medical checkup and blood/urine tests.
- You are not taking any medicines that affect heart rhythm (like certain diuretics) or drugs that raise uric acid (like pyrazinamide).
- You have no history of gout, long QT syndrome, or heart problems.
- Men must agree to use condoms and provide semen samples; women must use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how safe and tolerable different doses of Ingavirin Forte are in healthy people. It helps find the right dose for future studies.
This study compares two versions of an antiviral medicine called Ingavirin to see how your body processes them and whether they are safe. Researchers will give you the medicine on an empty stomach and after eating to understand how food affects how your body absorbs it.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
Hear when a new Infectious Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.